ONC

#424
BeOne Medicines Ltd - American Depositary Shares
293.3 7 USD
+0.96%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
292.07
294.16
Faixa anual
3.05
385.22
Mudança diária
+0.96%
Mudança mensal
+0.70%
Mudança em 6 meses
-13.30%
Mudança anual
-7.07%
Fechamento anterior
290.5 8
Open
292.0 7
Mínimo
292.0 7
High
294.1 6
Volume
36
Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
Demonstração de resultados Balanço patrimonial Fluxo de caixa
Valor 202020212022202320242025 TTM

BeOne Medicines Ltd - American Depositary Shares

BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment. Founded in 2010 by chief executive officer John V. Oyler and Xiaodong Wang, the company is headquartered in Cambridge, Massachusetts and has locations on six continents, in over 45 countries. BeOne has a large presence in the Chinese market. BeOne Medicines has developed several medicines, including tislelizumab, a checkpoint inhibitor, and zanubrutinib, a Bruton's tyrosine kinase inhibitor. On 14 November 2024 the company announced its intention to rebrand as BeOne Medicines. BeOne changed its stock ticker to ONC in January 2025 and redomiciled to Basel, Switzerland in May 2025.